UCB (EBR:UCB) UCB Media Room: Transparency notification FMR LLC
Directive transparence : information réglementée Communiqué sur comptes, résultats, chiffres d’affaires
26/05/2023 20:00
https://mb.cision.com/Public/18595/3775771/ad3c6efe37399dd8_800x800ar.png
** Transparency notification FMR LLC
------------------------------------------------------------
Brussels (Belgium), 26 May 2023 =E2=80=93 20:00 (CEST) =E2=80=93 Regulated =
information=C2=A0
1. Summary of the notification
Pursuant to Article 14 of the law of 2 May 2007 on the disclosure of large =
shareholdings, UCB SA/NV announces that it received a transparency notifica=
tion from FMR LLC. (having its registered office at The Corporation Trust C=
enter, 1209 Orange Street, Wilmington, New Castle County, Delaware, 19801, =
U.S.A.) on 24 May 2023.=C2=A0
FMR LLC., notified that, following an acquisition of UCB shares with voting=
rights by its affiliates, its shareholding in UCB SA increased and crossed=
the 3% threshold on 19 May 2023.
On 19 May 2023, FMR LLC. (taking into account the holding of its affiliates=
) owned 8 502 358 UCB shares with voting rights, representing 4.37% of the =
total number of shares issued by the company (194 505 658), versus 3.86% (7=
509 016 UCB shares) in the previous notification dated 3 August 2022.
2. Content of the notification
=C2=B7 Reason for the notification: Acquisition or disposal of voting secur=
ities or voting rights.=C2=A0
=C2=B7 Notification by: A parent undertaking or a controlling person.
=C2=B7 Persons subject to the notification requirement:=C2=A0
https://mb.cision.com/Public/18595/3775771/af2a5c86b99ba989_800x800ar.png
=C2=B7 Date on which the threshold is crossed: 19 May 2023.=C2=A0
=C2=B7 Threshold crossed (in %): 3%.
=C2=B7 Denominator: 194 505 658.
=C2=B7 Notified details:
=C2=A0https://mb.cision.com/Public/18595/3775771/a9b2ca8ed26006b3_800x800ar=
.png
=C2=A0
=C2=B7 Chain of controlled undertakings through which the holding is effect=
ively held:
=C2=A0https://mb.cision.com/Public/18595/3775771/834640f0789275e8_800x800ar=
.png
=C2=B7 Additional information: The holdings attributed to the entities ment=
ioned in heading 10 arise from holdings of various undertakings for collect=
ive investment that are managed by FIAM LLC, Fidelity Institutional Asset M=
anagement Trust Company, Fidelity Management & Research Company LLC, Fideli=
ty Management Trust Company, FMR Investment Management (UK) Limited and Str=
ategic Advisers LLC each of which are entities that are subsidiaries of and=
controlled by FMR LLC. The entities mentioned in heading 10 are the discre=
tionary investment managers and exercise the voting rights at their discret=
ion in the absence of specific instructions. Threshold crossed by a Control=
led Undertaking.
3. Further information=C2=A0
This press release and the detailed transparency notification are available=
on UCB SA/NV=E2=80=99s website via the following link (https://www.ucb.com=
/investors/UCB-shareholders/Transparency-notifications) .
An updated overview of the UCB SA/NV large shareholdings will be available =
on UCB SA/NV=E2=80=99s website via the following link (https://www.ucb.com/=
investors/UCB-shareholders) .
For further information, contact UCB:=C2=A0
Investor Relations
Antje Witte=C2=A0
T +32 2 559 94 14
antje.witte@ucb.com
Corporate Communications
Laurent Schots=C2=A0
T+32 2 559 92 64
laurent.schots@ucb.com =C2=A0=C2=A0 =C2=A0
About UCB
UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company =
focused on the discovery and development of innovative medicines and soluti=
ons to transform the lives of people living with severe diseases of the imm=
une system or of the central nervous system. With approximately 8 600 peopl=
e in nearly 40 countries, the company generated revenue of =E2=82=AC 5.8 bi=
llion in 2021. UCB is listed on Euronext Brussels (symbol: UCB). Follow us =
on Twitter: @UCB_news
=C2=A0
GenericFile
230519 - CdP Notification de transparence FMR LLC (https://mb.cision.com/Pu=
blic/18595/3775771/882fe393d4cdd64b.pdf) GenericFile
230519 PB Transparantieverklaring FMR LLC (https://mb.cision.com/Public/185=
95/3775771/97c71740352461ae.pdf) GenericFile
230519 PR Transparency notification FMR LLC (https://mb.cision.com/Public/1=
8595/3775771/a6cf13c43127119a.pdf) Image
Chart 1 May 26 2023 ENG (https://mb.cision.com/Public/18595/3775771/af2a5c8=
6b99ba989_org.png) Image
Chart 3 May 26 2023 ENG (https://mb.cision.com/Public/18595/3775771/834640f=
0789275e8_org.png) Image
Chart 2 May 26 2023 ENG (https://mb.cision.com/Public/18595/3775771/a9b2ca8=
ed26006b3_org.png)
______________________
If you would rather not receive future communications from UCB SA, please g=
o to https://eu.vocuspr.com/OptOut.aspx?2973226x20421x137296x1x6868579x2400=
0x6&Email=3Dregnews%40symexglobal.com.
UCB SA, All=C3=A9e de la Recherche, 60 ., Brussels, . B - 1070 Belgium
26/04/2024 20:00
25/04/2024 18:00
25/04/2024 07:01
23/04/2024 20:00
22/04/2024 07:01
19/04/2024 20:00
17/04/2024 07:01
12/04/2024 20:00
12/04/2024 18:01
12/04/2024 07:01